Citius Pharmaceuticals Names Myron Holubiak To Board
This article was originally published in Scrip
Citius Pharmaceuticals has appointed former president of Roche Laboratories, Inc., USA, Myron Holubiak to its board – effective Oct. 1, 2015. Prior to being president, Holubiak held sales and marketing positions at Roche. Currently he is chair of the board at BioScrip, Inc., a member of the board of Assembly Biosciences, Inc.; and its predecessor Ventrus Biosciences, Inc.; and is also a founder of Leonard-Meron Biosciences, Inc., as well as its director and CEO.